Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results

    NEXT STORY
    resTORbio Appoints Lloyd Klickstein, M.D., Ph.D., as Chief Scientific Officer
    PREV STORY
    Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-Efficient and In Vivo Production of Antibody Therapeutics in Patients

    author_avatar
    NASDAQ Market News

    Cyclacel Pharmaceuticals Reports First Quarter 2018 Financial Results

    Conference Call Scheduled May 14, 2018 at 4:30 p.m. EDTBERKELEY HEIGHTS, N.J., May 14, ...

    author_avatar
    NASDAQ Market News

    Fortress Biotech Announces Breakthrough Therapy Designation for CUTX-101, Copper Histidinate, for the Treatment of Menkes Disease

    author_avatar
    NASDAQ Market News